Unanimous adcom's like Amarin are nice risks though. Got back in on the 11th and surprise very positive FDA announcement Friday! That was fun but I agree with you that price action was disappointing. AGRX is next up.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.